Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ARNTL2 |
| Upstream (Parents) |
|---|
| (<<) WT1 → ARNTL2 |
| (<<) SATB2 → ARNTL2 |
| (<<) CDKN2A → ARNTL2 |
| (<<) FOSL1 → ARNTL2 |
| (<<) MLXIPL → ARNTL2 |
| (<<) NR1I2 → ARNTL2 |
| (<<) JUN → ARNTL2 |
| (<<) HMX1 → ARNTL2 |
| (<<) EGR1 → ARNTL2 |
| (<<) BHLHE40 → ARNTL2 |
| (<<) LASS6 → ARNTL2 |
| Downstream (Children) |
|---|
| ARNTL2 → FOXG1 (>>) |
| ARNTL2 → ATOH1 (>>) |
| ARNTL2 → ISL1 (>>) |
| ARNTL2 → MXD1 (>>) |
| ARNTL2 → NPAS1 (>>) |
| ARNTL2 → TFAP2A (>>) |
| ARNTL2 → TP63 (>>) |
| ARNTL2 → POU6F2 (>>) |
| ARNTL2 → IRX4 (>>) |
| ARNTL2 → CREM (>>) |
| ARNTL2 → ZNF154 (>>) |
| ARNTL2 → ZNF639 (>>) |
| ARNTL2 → NKX2-5 (>>) |
| ARNTL2 → EGR2 (>>) |
| ARNTL2 → TSC22D4 (>>) |
| ARNTL2 → HEYL (>>) |
| ARNTL2 → GATA1 (>>) |
| ARNTL2 → HMBOX1 (>>) |
| ARNTL2 → RFX3 (>>) |
